XML 126 R112.htm IDEA: XBRL DOCUMENT v3.3.1.900
Financial Statement Schedule I (Details 6) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Operating activities:      
Net Income (loss) $ 173,316 $ 243,887 $ 45,565
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 94,217 82,627 80,821
Loss on disposal of property, plant and equipment 1,801 1,478 3,613
Loss on change in fair value of derivatives 12,196 (19,656) (10,764)
Allowance for doubtful debts 3,673 (8,528) (975)
Equity in loss of unconsolidated investees 643 (487) 3,064
Share-based compensation 5,966 5,088 6,175
Changes in operating assets and liabilities:      
Inventories 50,821 (252,716) 34,667
Accounts receivable trade (63,352) (73,777) (11,814)
Amounts due from related parties (99,893) 480 5,288
Advances to suppliers 7,967 (3,622) (5,747)
Prepaid expenses and other current assets 36,745 (38,523) (2,333)
Other non-current assets (22,355) (8,446) (4,420)
Accounts payable (23,975) 135,812 44,231
Advances from customers (30,123) 40,311 51,357
Amounts due to related parties 47,522 (2,166) 14,492
Accrued warranty costs 12,004 15,516 (19,199)
Liability for uncertain tax positions (1,111) (1,613) 2,495
Deferred taxes (112,263) 9,208 15,142
Settlement of derivatives 24,878 17,192 5,147
Net cash provided by operating activities 413,658 265,106 229,549
Investing activities:      
Decrease (increase) in restricted cash (100,935) (27,585) (10,099)
Investment in subsidiaries (84,389) (72) (4,278)
Purchase of property, plant and equipment (90,905) (49,660) (23,132)
Funding of loans to subsidiaries (196,783)    
Net cash used in investing activities (999,104) (116,049) (37,509)
Financing activities:      
Proceeds from short-term borrowings 1,436,950 928,879 768,381
Repayment of short-term borrowings (1,308,235) (1,045,596) (1,073,503)
Proceeds from long-term borrowings 487,228 56,989 149,832
Proceeds from issuance of warrants 16,378    
Proceeds from issuance of common shares offering   115,009 50,000
Issuance costs paid for common shares offering   (6,091) (2,113)
Proceeds from issuance of convertible notes   150,000  
Issuance cost paid on convertible notes (39,297)    
Proceeds from exercise of stock options 1,867 3,343 10,793
Net cash provided by (used in) financing activities 619,483 191,947 (104,900)
Effect of exchange rate changes (30,501) (19,711) (858)
Net increase in cash and cash equivalents 3,536 321,293 86,282
Cash and cash equivalents at the beginning of the year 549,543 228,250 141,968
Cash and cash equivalents at the end of the year 553,079 549,543 228,250
Supplemental disclosure of cash flow information:      
Interest paid 49,619 47,227 47,344
Income taxes paid 87,348 14,016 23,813
Parent Company      
Operating activities:      
Net Income (loss) 171,861 239,502 31,659
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 32 1 5
Loss on disposal of property, plant and equipment   4  
Loss on change in fair value of derivatives 13,571    
Allowance for doubtful debts 1,535 11,434 1,872
Equity in (earnings) loss of subsidiaries (193,813) (243,283) (35,132)
Equity in loss of unconsolidated investees 273 280 2,752
Share-based compensation 5,966 5,088 6,175
Changes in operating assets and liabilities:      
Inventories 296 (286) 2,828
Accounts receivable trade 2,189 (5,244) 627
Amounts due from related parties 228,284 3,905 85,993
Advances to suppliers (226) (11,836) (283)
Prepaid expenses and other current assets (7,106) (2,260) 8,312
Other non-current assets (14,710) (19,727) 6,860
Accounts payable 3 (9) 9
Advances from customers 1,352 (657) (122)
Amounts due to related parties 103,348 (42,128) (18,332)
Accrued warranty costs (2,941) 84 (14,644)
Other current liabilities 4,484 3,544 (2,558)
Liability for uncertain tax positions (1,111) 633 142
Deferred taxes 1,451 1,208 406
Settlement of derivatives (3,950)    
Net cash provided by operating activities 310,788 (59,747) 76,569
Investing activities:      
Decrease (increase) in restricted cash (6,513)    
Investment in subsidiaries (116,840) (39,668) (10,602)
Purchase of property, plant and equipment   (5)  
Funding of loans to subsidiaries (550,776) (128,213)  
Net cash used in investing activities (674,129) (167,886) (10,602)
Financing activities:      
Proceeds from short-term borrowings 10,000    
Repayment of short-term borrowings   (12,246) (55,754)
Proceeds from long-term borrowings 364,680    
Repayment of long-term borrowings   (16,393) (53,670)
Payment for repurchase of convertible senior notes 16,378    
Proceeds from issuance of warrants (918)    
Proceeds from issuance of common shares offering   115,009 50,000
Issuance costs paid for common shares offering   (6,090) (2,113)
Proceeds from issuance of convertible notes   150,000  
Issuance cost paid on convertible notes   (5,103)  
Proceeds from exercise of stock options 1,867 3,342 10,793
Net cash provided by (used in) financing activities 392,007 228,519 (50,744)
Effect of exchange rate changes 2,085 (27,016) 3,115
Net increase in cash and cash equivalents 30,751 (26,130) 18,338
Cash and cash equivalents at the beginning of the year 3,455 29,585 11,247
Cash and cash equivalents at the end of the year 34,206 3,455 29,585
Supplemental disclosure of cash flow information:      
Interest paid $ 15,299 3,942  
Income taxes paid   $ 736 $ 298